Insights into drug delivery across the nail plate barrier

MV Saner, AD Kulkarni, CV Pardeshi - Journal of drug targeting, 2014 - Taylor & Francis
Topical therapy is at the forefront in treating nail ailments (especially onychomycosis and
nail psoriasis) due to its local effects, which circumvents systemic adverse events, improves …

Insights into drug delivery across the nail plate barrier

MV Saner, AD Kulkarni… - Journal of drug …, 2014 - pubmed.ncbi.nlm.nih.gov
Topical therapy is at the forefront in treating nail ailments (especially onychomycosis and
nail psoriasis) due to its local effects, which circumvents systemic adverse events, improves …

Insights into drug delivery across the nail plate barrier.

MV Saner, AD Kulkarni, CV Pardeshi - Journal of Drug Targeting, 2014 - europepmc.org
Topical therapy is at the forefront in treating nail ailments (especially onychomycosis and
nail psoriasis) due to its local effects, which circumvents systemic adverse events, improves …

[引用][C] Insights into drug delivery across the nail plate barrier

MV Saner, AD Kulkarni, CV Pardeshi - Journal of Drug Targeting, 2014 - cir.nii.ac.jp
Insights into drug delivery across the nail plate barrier | CiNii Research CiNii 国立情報学研究所
学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …

[PDF][PDF] Insights into drug delivery across the nail plate barrier

MV Saner, AD Kulkarni, CV Pardeshi - J Drug Target, 2014 - academia.edu
Topical therapy is at the forefront in treating nail ailments (especially onychomycosis and
nail psoriasis) due to its local effects, which circumvents systemic adverse events, improves …

[PDF][PDF] Insights into drug delivery across the nail plate barrier

MV Saner, AD Kulkarni, CV Pardeshi - J Drug Target, 2014 - academia.edu
Topical therapy is at the forefront in treating nail ailments (especially onychomycosis and
nail psoriasis) due to its local effects, which circumvents systemic adverse events, improves …